Reference13 articles.
1. Issaq HJ, Conrads TP, Prieto DA, Tirumalai R, Veenstra TD (2003) SELDI-TOF MS for diagnostic proteomics. Anal Chem 75:148A–155A
2. Wibom C, Pettersson F, Sjöström M, Henriksson R, Johansson M, Bergenheim AT (2006) Protein expression in experimental malignant glioma varies over time and is altered by radiotherapy treatment. Br J Cancer 94:1853–1863
3. Wibom C, Moren L, Aarhus M, Knappskog PM, Lund-Johansen M, Antti H, Bergenheim AT (2009) Proteomic profiles differ between bone invasive and noninvasive benign meningiomas of fibrous and meningothelial subtype. J Neurooncol 94:321–331
4. CBTRUS (2009) CBTRUS 2009 Statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2004–2005, Central Brain Tumor Registry of the United States
5. Condra KS, Buatti JM, Mendenhall WM, Friedman WA, Marcus RB Jr, Rhoton AL (1997) Benign meningiomas: primary treatment selection affects survival. Int J Radiat Oncol Biol Phys 39:427–436
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献